8-K: Pasithea Therapeutics Corp. Holds 2024 Annual Meeting, Elects Director and Ratifies Auditor

Pasithea Therapeutics Corp. held its 2024 Annual Meeting of Stockholders, where a Class I director was elected and the appointment of Marcum LLP as the independent auditor was ratified.

Summary

• Pasithea Therapeutics Corp. held its 2024 Annual Meeting of Stockholders on June 26, 2024.
• A quorum was established with 369,617 shares represented out of 1,043,248 outstanding shares.
• The stockholders voted on two proposals: the election of a Class I director and the ratification of the appointment of Marcum LLP as the independent auditor.
• Dr. Emer Leahy was elected as a Class I director with a term expiring at the 2027 Annual Meeting.
• The appointment of Marcum LLP as the independent auditor for the fiscal year ending December 31, 2024, was ratified.

Sentiment

Score: 7

Explanation: The document reflects standard corporate governance procedures, indicating a neutral to slightly positive sentiment due to the successful completion of the annual meeting.

Positives

• The company successfully held its annual meeting and achieved a quorum.
• A new Class I director, Dr. Emer Leahy, was elected to the board.
• The appointment of Marcum LLP as the independent auditor was ratified, ensuring continued financial oversight.

Management Comments

• Tiago Reis Marques, Chief Executive Officer, signed the report on behalf of the company.

Industry Context

This is a standard corporate governance event for a publicly traded company, ensuring compliance with regulatory requirements and shareholder engagement.

Comparison to Industry Standards

• The election of directors and ratification of auditors are standard practices for publicly traded companies like Pasithea Therapeutics.
• The voting results are typical for such meetings, with a majority of votes cast in favor of the proposals.

Management Changes

Stakeholder Impact

• Shareholders have exercised their voting rights on key corporate matters.
• The election of a director and ratification of the auditor provide assurance of corporate governance.

Key Dates

Keywords

Annual Meeting, Stockholders, Director Election, Auditor Ratification, Corporate Governance, Pasithea Therapeutics, Marcum LLP